Washington manual of nephrology subspecialty 3rd edition PDF download


Washington manual of nephrology subspecialty 3rd edition:


WASHINGTON NEPHROLOGYThe Washington Manual of Nephrology Subspecialty Consult has been thoroughly updated and covers inpatient and outpatient

management of nephrology with the same clinical practicality as the widely-popular Washington Manual of Medical

Therapeutics. It has been written by the residents, fellows, and attending physicians of the distinguished Washington

University School of Medicine and is tailored for residents performing inpatient consults, students working on an inpatient

medicine service, and specialists seeking fast-access information on the management of common renal diseases. Organized

for quick and easy access to information, this handbook includes sections on general approaches to kidney disease, electrolyte

and acid-base disorders, acute kidney injury and continuous renal replacement, causes of kidney disease, pregnancy and

nephrolithiasis, and chronic kidney disease. Appendices include dosing adjustments for antimicrobials and antiretrovirals

and a listing of red flag drugs that may cause renal impairment.Don’t miss the other key topics in The Washington Manual

Subspecialty Consult Series:· Allergy, Asthma, and Immunology· Gastroenterology· Hematology and Oncology· Infectious

Disease· Rheumatology The Washington Manual is a registered mark belonging to Washington University in St. Louis to

which international legal protection applies. The mark is used in this publication by LWW under license from Washington

University.The field of nephrology is changing rapidly, as new advances change the management of acute kidney injury (AKI), chronic kidney disease,and renal transplantation. AKI continues to be a life-threatening problem for the hospitalized patient, and new clinical trials have addressed the role of intensive renal replacement therapy in AKI. Glomerulonephritides generate signiɹcant challenges to the nephrologist as we strive to treat the patient effectively but at the same time try to minimize side effects from the treatment regimen. Newer agents have been added as induction therapies to decrease rejection rates after renal transplantation. Early initiation of hemodialysis has recently been proven to be not beneficial inpatients with chronic kidney disease.

For full washington series let us know through the follow email below